Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Hearthero, Novocure.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Angiocrine, Bioxcel, Gyroscope, Inventiva, Sebela, Sorrento, Surface.
New and updated preclinical and clinical data presented by biopharma firms at the Society for Immunotherapy of Cancer’s annual meeting Nov. 9-14, including: Bergenbio, Exuma, Genexine, I-Mab, Imcheck, Innovent, Intensity, Jounce, Nektar, Shattuck, Sotio.